Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

F

FATE

Fate Therapeutics Inc

2.62

Aug 17 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX ZNTL REPL

| Held by: VTI VXF SCHA IWC VHT PRFZ BUSM SCHB AVSC DFMC

Scroll to Statements

Index	-
Market Cap	313.93M
Enterprise Value	235.83M
Income	-126.00M
Sales	6.49M
Book/sh	1.31
Cash/sh	1.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	48.37
P/B	1.99
P/C	2.04
P/FCF	-
EV/EBITDA	-
EV/Sales	36.34
Quick Ratio	4.85
Current Ratio	4.85
Debt/Eq	0.49
LT Debt/Eq	0.46
Option/Short	Yes / Yes

EPS (ttm)	-1.05
EPS next Y	-1.01
EPS next Q	-0.28
EPS this Y	5.93%
EPS next Y	6.45%
EPS next 5Y	3.38%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	27.52%
Sales Y/Y TTM	-23.36%
EPS Q/Q	12.84%
Sales Q/Q	9.18%
Earnings	Aug 13 BMO
EPS/Sales Surpr.	1.42% 4.99%

Insider Own	4.80%
Insider Trans	-2.33%
Inst Own	58.69%
Inst Trans	4.46%
ROA	-39.89%
ROE	-60.75%
ROIC	-56.20%
Gross Margin	-84.69%
Oper. Margin	-2058.08%
Profit Margin	-1941.09%
SMA20	2.14%
SMA50	4.96%
SMA200	60.69%
Trades

Shs Outstand	116.69M
Shs Float	110.97M
Short Float	6.92%
Short Ratio	2.06
Short Interest	7.68M
52W High	3.23 -18.89%
52W Low	0.93 180.66%
Volatility	7.01% 7.25%
ATR (14)	0.20
RSI (14)	51.07
Beta	2.56
Rel Volume	0.00
Avg Volume	3.73M
Volume	0

Perf Week	-5.07%
Perf Month	-5.76%
Perf Quarter	49.29%
Perf Half Y	109.60%
Perf YTD	166.64%
Perf Year	140.37%
Perf 3Y	-5.76%
Perf 5Y	-96.90%
Perf 10Y	-7.09%
Recom	2.00
Target Price	5.74
Prev Close	2.62
Price	2.62
Change %	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)